Michael Okunewitch Stock Analyst Profile - Maxim Group Research Coverage - Stocknear

Michael Okunewitch

Stock Analyst at Maxim Group

(2.85)
# 3060
Out of 5,506 analysts
30
Total ratings
Success rate
Average return

20 Stocks

Name Action PT Current % Upside Ratings Updated
CTOR Citius Oncology
Upgrades: Buy
6
1.89 217.46% 3 Sep 23, 2025
ANEB Anebulo Pharmaceutic...
Downgrades: Hold
n/a
n/a n/a 3 Jul 23, 2025
HCWB HCW Biologics
Maintains: Buy
120 35
4.04 766.34% 2 May 29, 2025
RADX Radiopharm Theranost...
Initiates Coverage On: Buy
12
6.2 93.55% 1 May 1, 2025
CMMB Chemomab Therapeutic...
Maintains: Strong Buy
16 28
2.72 929.41% 2 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
1.73 709.25% 1 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
1.67 79.64% 1 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
1.77 125.99% 1 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
0.55 2081.82% 1 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 6
0.79 659.49% 2 Aug 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
3 12
0.88 1263.64% 2 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2
n/a n/a 1 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
1.91 1156.54% 1 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
108 18
2.75 554.55% 3 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2025
2.53 79939.53% 1 Apr 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
17.19 45.43% 1 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.5 300% 1 Sep 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
n/a n/a 1 Feb 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
5.23 378.01% 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
100
1.37 7199.27% 1 Nov 30, 2021